Phio Pharmaceuticals Corp. (29)

Browse by Contract Category

Contracts

Form of Restricted Stock Unit Award under the Companys 2020 Long Term Incentive Plan (Filed With SEC on March 25, 2021)
Form of Securities Purchase Agreement, dated February 12, 2021, by and between the Company and the Purchasers signatory therein (Filed With SEC on February 17, 2021)
Description of Securities Registered Pursuant to Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 26, 2020)
Placement Agency Agreement, by and between Phio Pharmaceuticals Corp. and H.C. Wainwright & Co., LLC dated as of November 18, 2019 (Filed With SEC on November 20, 2019)
First Amendment to Lease Dated January 22, 2019 (Filed With SEC on January 28, 2019)
Form of Placement Agent Warrant (Filed With SEC on February 17, 2021)
Form of Registration Rights Agreement, dated January 21, 2021, by and between the Company and the Purchasers signatory therein (Filed With SEC on January 25, 2021)
Form of Securities Purchase Agreement, dated January 21, 2021, by and between the Company and the Purchasers signatory therein (Filed With SEC on January 25, 2021)
Form of Pre-Funded Common Stock Warrant (Filed With SEC on January 25, 2021)
Form of Common Stock Warrant (Filed With SEC on January 25, 2021)
Securities Purchase Agreement, dated March 31, 2020, by and between the Company and the Purchasers signatory therein (Filed With SEC on April 2, 2020)
Form of Common Stock Warrant (Filed With SEC on April 2, 2020)
Form of Common Stock Purchase Warrant (Filed With SEC on February 13, 2020)
Form of Underwriter Common Stock Purchase Warrant (Filed With SEC on February 13, 2020)
Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on February 13, 2020)
Underwriting Agreement, dated as of February 11, 2020, between Phio Pharmaceuticals Corp. and H.C. Wainwright & Co., LLC, as representative of the underwriters named therein (Filed With SEC on February 13, 2020)
Securities Purchase Agreement, dated February 4, 2020, by and between the Company and the Purchasers signatory therein (Filed With SEC on February 6, 2020)
Form of Common Stock Warrant (Filed With SEC on February 6, 2020)
Form of Underwriting Agreement (Filed With SEC on January 31, 2020)
Form of Warrant (Filed With SEC on January 31, 2020)
Form of Pre-Funded Warrant (Filed With SEC on January 31, 2020)
Form of Underwriter Warrant (Filed With SEC on January 31, 2020)
Form of Placement Agent Warrants of Phio Pharmaceuticals Corp (Filed With SEC on November 20, 2019)
Phio Pharmaceuticals Corp. 2012 Long Term Incentive Plan (Filed With SEC on November 12, 2019)
First Amendment to Purchase Agreement by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 30, 2019)
Registration Rights Agreement, dated as of August 7, 2019, by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 9, 2019)
Purchase Agreement, dated as of August 7, 2019 by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 9, 2019)
Employment Agreement, dated April 22, 2019, between Phio Pharmaceuticals Corp. and John A. Barrett, Ph.D (Filed With SEC on May 14, 2019)
Amendment No. 2 to Cauwenbergh Non-Plan Stock Compensation Election Agreement (Filed With SEC on February 15, 2019)